BioMarin Pharmaceutical Inc. is a leading global biotechnology company specializing in the development and commercialization of therapies for people with serious and life-threatening rare genetic dise... BioMarin Pharmaceutical Inc. is a leading global biotechnology company specializing in the development and commercialization of therapies for people with serious and life-threatening rare genetic diseases. Its portfolio includes eight approved treatments targeting conditions such as mucopolysaccharidosis types I, IVA, and VI (branded as Aldurazyme, Vimizim, and Naglazyme), phenylketonuria (Kuvan), achondroplasia (Voxzogo), Batten disease (Brineura), Lambert-Eaton myasthenic syndrome (Firdapse), and hemophilia A (Roctavian). These therapies encompass enzyme replacement therapies, gene therapies, and small molecule drugs designed to address the underlying genetic causes of these disorders. BioMarin Pharmaceutical Inc. operates in more than 70 countries across the United States, Europe, Latin America, the Middle East, and Asia Pacific, serving patient communities through innovative genetic science and molecular biology expertise. Founded in 1997 and headquartered in San Rafael, California, the company maintains a robust pipeline of clinical and preclinical candidates focused on skeletal dysplasias, liver diseases, and muscular dystrophies, reinforcing its pivotal role in the rare disease biotechnology sector.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for BioMarin Pharmaceutical

We have not yet reviewed BioMarin Pharmaceutical's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review BioMarin Pharmaceutical's data?

Start your 30-day free trial to request a data review for BioMarin Pharmaceutical.

Start Free Trial

Legal Center Contact Us

BioMarin Pharmaceutical Inc

Group Entities data not yet covered for BioMarin Pharmaceutical

Account Restricted